Secondary outcomes of 7-day PPAR and 1-month CAR at 1-month and 3-month follow-up (n=924)
| Follow-up | Quitting rates % (n) | OR (95% CI) | p Value |
|---|---|---|---|
| 7-day PPAR at 1 month | |||
| Varenicline | 40.1 (133/332) | 2.93 (2.17 to 3.96) | <0.001 |
| Counselling | 18.6 (110/592) | 1.00 | |
| 7-day PPAR at 3-month | |||
| Varenicline | 38.0 (126/332) | 2.01 (1.56 to 2.80) | <0.001 |
| Counselling | 22.6 (134/592) | 1.00 | |
| 1-month CAR at 3-month | |||
| Varenicline | 36.1 (120/332) | 2.51 (1.85 to 3.40) | <0.001 |
| Counselling | 18.4 (109/592) | 1.00 | |
CAR, continuous abstinence rate; PPAR, point prevalence abstinence rate.